In several water-breathing fish species, β-adrenergic receptor stimulation by noradrenaline leads to a decrease in plasma free fatty acid (FFA) levels, as opposed to an increase in air-breathing mammals. We hypothesised that this change in adrenergic control is related to the mode of breathing. Therefore, cannulated air-breathing African catfish were infused for 90·min with noradrenaline or with the nonselective β-agonist, isoprenaline. To identify the receptor type involved, a bolus of either a selective β 1 -antagonist (atenolol) or a selective β 2 -antagonist (ICI 118,551) was injected 15·min prior to the isoprenaline infusion. Both noradrenaline and isoprenaline led to an expected rise in glucose concentration. Isoprenaline combined with both the β 1 -and β 2 -antagonist led to higher glucose concentrations than isoprenaline alone. This could indicate the presence of a stimulatory β-adrenoceptor different from β 1 and β 2 -adrenoceptors; these two receptors thus seemed to mediate a reduction in plasma glucose concentration. Both noradrenaline and isoprenaline led to a significant decrease in FFA concentration. Whereas the β 1 -antagonist had no effect, the β 2 -antagonist reduced the decrease in FFA concentration, indicating the involvement of β 2 -adrenoceptors. It is concluded that the air-breathing African catfish reflects water-breathing fish in the adrenergic control of plasma FFA and glucose levels.